<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(1)</volume><submitter>Piccolo S</submitter><pubmed_abstract>Our understanding of the function of the transcriptional regulators YAP and TAZ (YAP/TAZ) in cancer is advancing. In this Review, we provide an update on recent progress in YAP/TAZ biology, their regulation by Hippo signaling and mechanotransduction and highlight open questions. YAP/TAZ signaling is an addiction shared by multiple tumor types and their microenvironments, providing many malignant attributes. As such, it represents an important vulnerability that may offer a broad window of therapeutic efficacy, and here we give an overview of the current treatment strategies and pioneering clinical trials.</pubmed_abstract><journal>Nature cancer</journal><pagination>9-26</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7614914</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches.</pubmed_title><pmcid>PMC7614914</pmcid><pubmed_authors>Contessotto P</pubmed_authors><pubmed_authors>Cordenonsi M</pubmed_authors><pubmed_authors>Piccolo S</pubmed_authors><pubmed_authors>Panciera T</pubmed_authors></additional><is_claimable>false</is_claimable><name>YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches.</name><description>Our understanding of the function of the transcriptional regulators YAP and TAZ (YAP/TAZ) in cancer is advancing. In this Review, we provide an update on recent progress in YAP/TAZ biology, their regulation by Hippo signaling and mechanotransduction and highlight open questions. YAP/TAZ signaling is an addiction shared by multiple tumor types and their microenvironments, providing many malignant attributes. As such, it represents an important vulnerability that may offer a broad window of therapeutic efficacy, and here we give an overview of the current treatment strategies and pioneering clinical trials.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-18T22:31:32.242Z</modification><creation>2025-04-07T10:13:53.036Z</creation></dates><accession>S-EPMC7614914</accession><cross_references><pubmed>36564601</pubmed><doi>10.1038/s43018-022-00473-z</doi></cross_references></HashMap>